Conference Schedule
|
Date |
Time |
Content |
Venue |
|
18th,Sept. |
13:00-16:30 |
Register |
Beijing National Engineering Research Center hall F1 |
|
19th,Sept. |
08:00-08:35 |
Register |
Beijing National Engineering Research Center hall F1 |
|
08:35-09:00 |
Opening ceremony |
Beijing National Engineering Research Center hall F1 | |
|
09:00-12:00 |
Keynote Presentations |
Beijing National Engineering Research Center hall F1 | |
|
12:10-13:30 |
Networking Luncheon |
Dining-room | |
|
13:30-18:15 |
Keynote Presentations |
Beijing National Engineering Research Center hall F1 | |
|
18:30-21:00 |
Appreciation dinner |
Lake Front | |
|
20th,Sept. |
09:00-12:30 |
CRO and Global Outsourcing Presentations Forum |
Innovative Building, Auditorium, F2 |
|
09:00-12:30 |
Intellectual Property Protection Forum |
Innovative Building, Auditorium, F2 | |
|
09:00-12:30 |
Pharmaceutical Industry Focus Forum |
Innovative Building, Auditorium, F2 | |
|
12:30-13:20 |
Networking Luncheon |
Innovative Building, Auditorium, F2 | |
|
13:30-18:00 |
ANDA Application and cGMP Transformation Forum |
Innovative Building, Auditorium, F2 | |
|
13:30-18:00 |
New Drug Technology Innovation Forum |
Innovative Building, Auditorium, F2 | |
|
13:30-18:00 |
Pharmaceutical Investment and Financing Forum |
Innovative Building, Auditorium, F2 | |
|
21st,Sept. |
09:00-15:00 |
Local Visit Program (Visiting Biomedical Enterprises) |
Zhongguancun Science Park |
Back To Top
AGENDA£ºCHINA LIFE SCIENCE SUMMIT-BEIJING2007
| 19th, Sept. 2007 9:00-18:15 | Venue: CapitalBio Auditorium F1 |
| Time | Keynote Presentations |
| 9:00£12:00 | Moderator: Hua-Cheng Wei£¬PhD Chairman BPGC, Fu-Chu He Academician 9:00-9:10 Qing Jun Dai Director of China Pharmaceutical Enterprises Management Welcome and Introduction 9:10-9:40 Zhen Wu, Vice Director of State Food and Drug Administration Perfect in policy and scientific monitoring 9:40-10:10 Tom Dietz , President of Pacific Growth Equity International life pharmaceutical capital market 10:10-10:30 Tea break 10:30-11:00 Mingde Yu, Vice Director of China Pharmaceutical Enterprises Management Association The new opportunities for pharmaceutical industry 11:00-11:30 Yougang Chen, Partner McKinsey Living strategy for Chinese pharmaceutical enterprises in a volatile environment 11:30-12:00 Interaction |
| 12:10£13:30 | Networking Luncheon |
| 13:30£18:15 | Moderator: Han-Cheng Zhang, Chairman of SAPA ; Jing Cheng,Prof. CEO CapitalBio 13:30-13:45 Shu-Guang Yuan, Director of Zhongguancun Life Science Park Being a bio-pharmaceuticals innovation centre 13:45-14:15 Mickael Wise£¬Partner, Perkins Coie LLP Drug innovation and the application and protection of patent 14:15-14:45 Boyi Qin, Academician On our drug innovation 14:45-15:15 Yehong Zhang VP Great China IMS The Trends and Implication of the World Generic Market 15:15-15:45 Hua-Cheng Wei£¬PhD Chairman BPGC Opportunities and exploring for Chinese pharmaceutical enterprise 15:45-16:00 Tea break 16:15-16:45 Jing-yu Bai, Vice Director, National Development and Reform Commission, Department of High-Tech Industry Formulate and implement strategies China Bio-Industry 16:45-17:15 Andrew Forman, WR Hambrecht + Co (WRH+Co) The international capital market operation of Chinese pharmaceutical enterprises 17:15-17:45 Han-Cheng Zhang , Chairman of SAPA Win-win cooperation, Speed Up The Innovative Drug R&D 17:45-18:15 Interaction |
| 18:30-21:00 | Networking Reception |
| 20th, Sept. 2007 9:00-18:00 | Venue: Innovation Works, Auditorium One, F2 |
| Time | Focus on Chinese Pharmaceutical Policy |
| 9:00£12:30 | Moderator: Mingde Yu, Vice Director CPEMA 9:00-9:30 Yan Luo, ,National Development and Reform Commission, Department of Price Creating the legal environment for the pharmaceutical industry development healthily 9:30-10:00 Guo-en Liu, Prof. China Economy Research Center, Beijing Univ. The way for China healthcare system reform 10:00-10:30 Xuying Yin, President of Beijing Zizhu Pharmaceutical Co., Ltd. Fitting into Chinese pharmaceutical enterprises growing environment 10:30-10:45 Tea break 10:45-11:15 Baoquan Zhu, Dean of Shanghai Institute of Biomedical Engineering The comparison of Chinese and Indian International pharmaceutical development 11:15-11:45 Mingfu Wang, President of H&J Consulting Company Capital market change the pattern of competition in pharmaceutical enterprises 11:45-12:15 Qinggong Wu , Partner of H&J Consulting Company, VP Changes brewing in pharmaceutical industry 12:15-12:30 Interaction |
| 12:30£13:20 | Networking Luncheon |
| CRO and Global Outsourcing | |
| 13:30£18:00 | Moderator: Xuemei Song, CEO of Venturepharm; Lixin Jiang, CEO of VGTC 13:30-13:45 Meihan Wu, General Manager Zhongguancun Science Park The establishment of biomedical R&D outsourcing services platform 13:45-14:15 Honggang Bi, General Manager China, VP, Covance Covance central laboratory in China - Focus on serving clients 14:15-14:45 Zhongsheng Yu, Vice President of The National Institutes of Pharmaceutical R&D Co., Ltd. The experience and the path to enter international outsourcing business 14:45-15:15 FRED MA PhD£¬CEO£¬MQI Global outsourcing and China CRO business. What and How? 15:15-15:45 Nigel A. Beeley, BioDuro(Beijing)Co.,Ltd Outsourcing-from Discovery to Clinic Trial 15:45-16:00 Tea break 16:00-16:30 Guang Yang, CSO Sinocro Inc. The new industrial direction of pharmaceutical outsourcing services 16:30-17:00 Yangbin Huang, Deputy General Manager, Newsummit Biopharm Group Innovated new drug developing model 17:00-17:20 Shou-shu Jiao CEO Tarcine BioMed Inc. The strategy for pre-clinical CRO 17:20-18:00 Interaction |
| 18:30-21:00 |
| 20th, Sept. 2007 9:00-18:15 | Venue: Innovation Works, Auditorium two, F2 |
| Time | Drug IP Protection and The Strategy |
| 9:00£12:20 | Moderator: James J. Zhu, Perkins Coie LLP; Dawson Zhu, VP of Beijing Double-crane Pharmaceutical Co.,Ltd. 9:00 - 9:20 Wu-Zhong Zeng, Director, State Intellectual Property Office Intellectual Property Strategies for Biotechnology Industry Development 9:20 - 9:40 James J. Zhu, Partner, Perkins Coie LLP Patent as a channel to the global market 9:40 - 10:00 Cheng-Jian Jiang, Managing Partner, Pekung Intellectual Property Agent The 3rd Round Patent Law Amendment and Impact on BioPharmaceutical 10:00 - 10:20 Tony Chen, Partner, Jone Day LLP Patent Strategy for Chinese Life Science Companies 10:20 - 10:40 Hao Xu, PhD, Wan Hui Da Guan Qin Law Firm How to strengthen trademark protection for pharmaceutical company 10:40 - 11:00 Tea break 11:00 - 11:40 Panel Discussion on intellectual property matters in venture investment Panelists: Steven Gao, General Manager, Xiamen Yst Biotech Co. Ltd. Jimmy Wei, Hutchison Whampoa (China) Limited Zoe Wang, Attorney at Law, Perkins Coie LLP Benjamin Cheng, Managing Director, Burrill & Company Great China Weijie Tang, Partner, CCPIT Patent and Trademark Law Office 11:40 - 12:20 Panel Discussion on intellectual property matters in technology transfer & licensing Panelists: Dawson Zhu, VP, Double-Crane Pharmaceutical Corp. Weishi Li, Attorney at Law, O'Melveny & Myers LLP Sean Cafey, Director, University of Southern California Donxu Qiu, Managing Partner, Huya Bioceince |
| 12:00£13:30 | Networking Luncheon |
| Development and Financing | |
| 13:30£18:00 | Moderator: Nathan Zhang, CEO of Sinocro Inc.; Xinhui Luan, CEO Molecular Sci.& Tech. 13:30-14:00 Guiguang Su, Zhongguancun CMC Investment environments and Biotech cluster of Beijing Life Science Park 14:00-14:30 Mark Tang, Chairman & Managing Partner World Tech Ventures, LLC State of Investing in China Biopharm from US Capital Market: What has worked? 14:30 -15:00 Nathan ZHANG, CEO of Sinocro Inc. New Capital Market Focus- Chinese R&D Outsourcing Industry 15:00 -15:30 Sam Thong£¬ Director , Morgan Stanley (Invited) IPO Basics for Chinese Life Science Companie 15:30-15:45 Tea break 15:45-16:15 Chika Yoshinaga(Yao) VP, Sofinnova Partners Asia Life Science 16:15-16:45 Marietta Wu, VP Burrill & Company Great China China in the Global Life Sciences Landscape 16:45-17:15 Hui Hsing Ma£¬Venture Partner of TVM Capita Funding of early stage life sciences innovation 17:15-18:00 Interaction |
| 20th, Sept. 2007 9:00-18:00 | Venue: Innovation Works, Auditorium Three, F2 |
| Time | ANDA and cGMP |
| 9:00£12:15 | Moderator: James J Ho, CEO Peking Union-Lawke; Yu Zhang, VP of Beijing Double-Crane Pharmaceutical 9:00-9:30 Ron Connolly, VP, Frontage Laboratories, Inc. The hope of cooperation and objectives with Chinese pharmaceutical enterprises 9:30-10:00 Ruyi He£¬ Ph.D£¬ FDA CDER IND/NDA filing and review 10:00-10:30 Weiyong Li PhD Analytical Development, Johnson & Johnson Pharmaceutical Research & Development, LLC Quality by Design (QbD) as a New Trend in the 21st Century Pharmaceutical Quality System and its Impact on Innovative & Generic Drug Product Development 10:30-10:45 Tea break 10:45-11:15 Lei Zhang, PhD, Biologics Consulting Group Inc New Opportunity for Chinese Pharmaceuticals: Development of Antibody-Based Drug 11:15-11:45 Frances J.Richmond,Ph.D Director and Research Professor Regulatory Science Program School of Pharmacy New rules for US Dietary supplements 11:45-12:15 Guo-zhong Rui, Director, China Pharmaceutical Technology Transfer Center The strategy in the development of generic drugs |
| 12:30£13:30 | Networking Luncheon |
| New Drug Development | |
| 13:30£18:00 | Moderator: Jason Jin VP Shanghai Biochip; Xinhui Luan CEO Molecular Tech. 13:30-13:55 Winston Parick Kuo, Director of Center of Emerging Technologies for Translational Medicine, Harvard Medical School New trend of emerging technologies for translational medicine and drug R&D 13:55-14:20 Zixin Qiu, CEO of Wantai Biological Pharmacy Enterprise Co., Ltd Hepatitis E-potential threats 14:20-14:45 Neng-Yang Shih, Ph.D , Executive Director From marijuana to modern medicines: recent advances in cannabinoid receptor ligands£¬Schering-Plough 14:45-15:10 Xingguo Mei, Professor, The Academy of Military Medical Science Nanoparticales of targeted drug delivery system£Principle and application 15:10-15:30 Tea break 15:30-15:55 Jian Ni, Chief Scientist, CEO, Human Antibodomics The application and progress of genomic and antibody drugs 15:55-16:20 Jason Jin£¬VP Shanghai Biochip Co.,Ltd. The development trend and science policy of new drug development 16:20-16:45 Yu Zhang, VP R&D and innovation for China pharmaceutical industry 16:45-17:10 Yu-jian Kang, PhD. CEO, InnoRem The new role of TCM in ND R&D 17:10-17:35 Danlei Shen, Aptar Suzhou Nasal drug delivery: New development and marker trends 17:35-18:00 Interaction |
Back To Top
Registration
Registration fee (in USD$)
- Registration fee includes all materials such as literature collection, calendars and directories, as well as lunch, dinner and refreshments, but excluding accommodation
- Register at http://www.chinalifescience.org
|
Date |
Regular member |
Student or Fellows |
|
7/1/07 -8/15/07 |
$977 |
$497 |
|
8/16/07 - 9/17/07 |
$1,197 |
$597 |
|
9/18, 9/19 |
$1,497 |
$797 |
Back
To Top
Sponsor:
This summit is the elite Celebration event of pharmaceutical industry, as well as the ideal platform to display image and improve brand awareness. The organizing committee has set up a number of sponsorship, and warmly welcomes variety of community participation. For details of the summit sponsorship please contact:
Contact Information:
- Central Research Institute, Beijing Pharmaceutical Group Company (BPGC)
- Contact Persons: Gu Xiaohong, Pan Jun, Zhang Shiwei
- Tel: +8610 65926068, +8610 65025120
- Fax: +8610 65922902
- Email: clss2007@126.com
- Please log on www.chinalifescience.org
Preview
China Life Sciences Summit ¡¤ Beijing 2007 promises to be another important international event of Chinese pharmaceutical industry. There will be Chinese government officials, experts, academics and industry leaders, well-known international pharmaceutical enterprises, VCs invested enterprises and the FDA experts to come together, centering on "cooperation and win-win" theme and three simultaneous tracks with six forums. Come join us in all six forums: International CRO Business Development Trends, pharmaceutical intellectual property protection, Pharmaceutical Industry Investment and Financing, preparation exports of ANDA and cGMP, Chinese new drug technology innovation, Pharmaceutical industry focus..
19th, September
Main Conference
Improve policy, scientific monitoring; The development and future of Pharmaceutical Industry in 2007; Drug innovation and the application and protection of patent......
20th, September
Six Forums:
CRO and Global Outsourcing Presentations Forum
CRO of Multinational pharmaceutical enterprises; Foreign pharmaceutical enterprises cooperate with the CRO experience or classic cases; The new industrial direction of Pharmaceutical outsourcing services......
Intellectual Property protection Forum
Intellectual Property Strategies for Biotechnology Industry Development; Patent as a channel to the global market; Discussion on intellectual property matters in venture investment......
Chinese pharmaceutical Investment and Financing Forum
New Capital Market Focus- Chinese Life Sciences Industry; The international capital market operation of Chinese pharmaceutical enterprises; Venture and private equity investments in China life sciences......
ANDA application and cGMP transformation Forum
Common errors and case analysis in China CGMP implementing process; The hope of cooperation and objectives with Chinese pharmaceutical enterprises; The technical standards and approval progress of American Chemical drug register application......
New Drug Technology Innovation Forum
Win-win cooperation, speed up the development of the global pharmaceutical industry; The principle and application of High targeting nano-delivery system; The development trend and science policy of new drug development......
Chinese Pharmaceutical Industry Focus Forum
Creating the legal environment for the pharmaceutical industry development healthily; Considering of the Chinese pharmaceutical enterprises growing environment; Program design of medical reform......
Back To Top
Contact Information:
Central Research Institute, Beijing Pharmaceutical Group Company (BPGC)
Contact Persons: Zhang Shiwei, Liran Wang, Pan Jun, Xuelian Xu
Tel: +8610 65926068, +8610 65922902
Fax: +8610 65922902
Email:
clss2007@126.com
Please log on www.chinalifescience.org
Back To Top